Home | Fresh | Popular | Industry Podcasts | Newsletter | LinkedIn | Instagram | EPN Journal | Contact

MTA Champions Diversity in Clinical Trials Ahead of FDA’s Latest Draft Guidance

29 July 2024 | By: Miller Tanner Associates Team | Publisher: Miller Tanner Associates

MTA Champions Diversity in Clinical Trials Ahead of FDA’s Latest Draft Guidance FDA Issues Diversity Action Plan Draft Guidance The US Food and Drug Administration (FDA) has issued a preliminary guideline advocating for more diverse patient groups in clinical trials. This initiative aims to enhance the quality of data submitted in support of premarket applications. The guideline outlines aspects that sponsors should include in their Diversity Action Plans as directed by Congress.

Read more of this post ⊳

 Vote this post up | Rank:146

Recent posts from Miller Tanner Associates

EPN Daily is independent and community-supported. Aggregating the latest news, articles, and podcasts from across the event industry to help professionals stay informed.

Recommended reading

EPN Journal Podcast
On Spotify, Apple Podcasts & Amazon Music

Daily newsletter

Get updates from EPN Daily direct to your inbox Monday to Friday with the free newsletter - learn more ⊳

EPN Partners

Latest podcast episodes

Discover more episodes ⊳